Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Flagrante Delictu who wrote (18396)	4/1/1998 4:16:00 AM
From: bluejeans	Read Replies (6) \| Respond to of 32384

STEROIDS The primary objective of Ligand's sex steroid program is to define agonists, partial agonists and antagonists of the sex steroid receptors as drugs for hormonally responsive cancers of men and women, hormone replacement therapies and the treatment and prevention of diseases affecting women's health as well as hormonal disorders prevalent in men. I thought it was just men will be boys. Which reminds me of a Clinton joke. Bob PS. this is one of my favorite days of the year. A guy told his doctor that "I think my wife is dead." The doctor asked what evidence he had to support his belief. Well said the guy, "our sex is about the same, but the dishes are starting to pile up in the sink."